Literature DB >> 8669952

Growth and endocrine function after near total pancreatectomy for hyperinsulinaemic hypoglycaemia.

A T Soliman1, I Alsalmi, A Darwish, M G Asfour.   

Abstract

Seven children, with a mean (SD) age of 4.6 (2.1) years, who as infants (21 (7.5) days) underwent near total (95-98%) pancreatectomy for persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI) were studied. At birth all the infants were macrosomic. Four infants had been born after a difficult labour, of whom three had moderate birth asphyxia and respiratory distress. All had normal thyroid function. After surgery transient hyperglycaemia was manifest in six of the children and required insulin treatment for 5.8 (3.8) weeks, and transient hypoglycaemia was encountered in one child and responded well to increased carbohydrate intake and diazoxide for three weeks. Six of the children rapidly crossed down their length and weight centiles during the first year after surgery. At the end of the first year these children were at or below the 5th centile of height and weight for their age and gender. After a period of 4.6 (2.1) years, their mean (SD) height score was -2.57 (0.5), growth velocity 3.9 (0.75) cm/year, and growth velocity SD score -2.1 (0.55)l these were significantly low and denoted significant growth retardation. The growth hormone peak responses to provocation with clonidine were normal (13.5 (2.8) micrograms/l). However, the circulating insulin-like growth factor-I (IGF-I) concentrations were significantly decreased (79 (34) ng/ml). Three of the children developed diabetes at two and a half, five, and seven years after surgery, two others had impaired oral glucose tolerance and six out of the seven children had an impaired C peptide response to glucagon. Defective insulin secretion in these children might directly inhibit IGF-I synthesis in the liver. The body mass index of the pancreatectomised children was 14.9 (0.5) and was normal for age and gender; they had a normal 72 hour faecal fat content and normal serum albumin concentration. These data indicated grossly adequate exocrine pancreatic function. It appears that children requiring near total pancreatectomy for PHHI have normal developmental milestones but defective linear growth with impaired insulin secretion and low IGF-I production despite normal growth hormone response to provocation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8669952      PMCID: PMC1511540          DOI: 10.1136/adc.74.5.379

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  53 in total

1.  Growth progression and 24-hour hormone profile in an infant treated chronically with a long-acting somatostatin derivative.

Authors:  A Rodriguez; E del Pozo; M D Rodriguez-Arnao; A Gómez-Pan
Journal:  Horm Res       Date:  1991

Review 2.  The insulin-like growth factors.

Authors:  W S Cohick; D R Clemmons
Journal:  Annu Rev Physiol       Date:  1993       Impact factor: 19.318

3.  Diabetes in pregnancy.

Authors:  R Fraser
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-11       Impact factor: 5.747

Review 4.  Growth hormone and surgery.

Authors:  A Revhaug; M Mjaaland
Journal:  Horm Res       Date:  1993

Review 5.  Acquired growth hormone resistance in patients with hypercatabolism.

Authors:  J Bentham; J Rodriguez-Arnao; R J Ross
Journal:  Horm Res       Date:  1993

6.  Familial hyperinsulinism maps to chromosome 11p14-15.1, 30 cM centromeric to the insulin gene.

Authors:  B Glaser; K C Chiu; R Anker; A Nestorowicz; H Landau; H Ben-Bassat; Z Shlomai; N Kaiser; P S Thornton; C A Stanley
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

7.  Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up.

Authors:  G Leibowitz; B Glaser; A A Higazi; M Salameh; E Cerasi; H Landau
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

8.  Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy.

Authors:  B Glaser; H J Hirsch; H Landau
Journal:  J Pediatr       Date:  1993-10       Impact factor: 4.406

9.  Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus.

Authors:  D R Salvesen; J M Brudenell; R J Snijders; R M Ireland; K H Nicolaides
Journal:  Am J Obstet Gynecol       Date:  1993-01       Impact factor: 8.661

10.  Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes.

Authors:  K Brismar; E Fernqvist-Forbes; J Wahren; K Hall
Journal:  J Clin Endocrinol Metab       Date:  1994-09       Impact factor: 5.958

View more
  3 in total

1.  Pancreatic exocrine and endocrine function after pancreatectomy for persistent hyperinsulinaemic hypoglycaemia of infancy.

Authors:  A Cade; M Walters; J W Puntis; R J Arthur; M D Stringer
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

2.  Permanent neonatal diabetes mellitus: epidemiology, mode of presentation, pathogenesis and growth.

Authors:  A T Soliman; M M elZalabany; B Bappal; I alSalmi; V de Silva; M Asfour
Journal:  Indian J Pediatr       Date:  1999 May-Jun       Impact factor: 1.967

3.  A case of persistent hyperinsulinemic hypoglycemia of infancy successfully managed with subcutaneous octreotide injection and nocturnal intravenous glucose supply.

Authors:  Mari Murakami; Sotaro Mushiake; Hiroko Kashiwagi; Yuri Etani; Yoko Miyoshi; Keiichi Ozono
Journal:  Clin Pediatr Endocrinol       Date:  2007-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.